Faltering growth (short stature, drop across centiles)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Short stature or faltering height
Laboratory tests
- FBC
- Serum ferritin (if anaemia, microcytosis or nutritional or digestive clue)if neededAnaemia or microcytosis on the FBC, with a nutritional pointer (restrictive diet, possible iron deficiency) or digestive pointer (coeliac disease, inflammatory bowel disease): anaemia can reveal iron deficiency, coeliac disease or IBD [1]. The Dutch screening measures iron and ferritin only if haemoglobinopathy is suspected in an at-risk population [1]; serum ferritin is not part of the French baseline tests [2].
- CRP (if inflammatory or digestive clue)if neededInflammatory or digestive pointer: abdominal pain, diarrhoea, blood or mucus in the stools, fatigue, arthritis; slowing of growth in height with poor weight gain (Crohn's disease, juvenile arthritis) [2]. Dutch screening suggests it (with the white cell count and faecal calprotectin) in children aged 10 or over whose height is flattening and whose BMI is low or falling, and it can be considered earlier with the same profile [1]. The French baseline tests include the erythrocyte sedimentation rate, which is no longer in the fee schedule [2,3]. The Italian consensus (2026) places CRP among the tests to request in primary care for any short stature [4]; neither serum ferritin nor serum albumin features there [4].
- Serum electrolytes
- Bicarbonate
- Serum creatinine
- Serum calcium
- Serum phosphate
- Alkaline phosphatase
- ASTif needednon-French guidelineChronic disease or suspected liver disease: an American Family Physician review suggests liver and kidney tests when the clinical picture points to liver or kidney disease (expert opinion, 2015) [5], and the 2026 Italian consensus counts transaminases and GGT among the tests to do in primary care for any short stature [4]. The French paediatricians' baseline tests do not include them [2]. Liver disease also lowers IGF-1 [6].
- ALTif needednon-French guidelineChronic disease or suspected liver disease: an American Family Physician review suggests liver and kidney tests when the clinical picture points to liver or kidney disease (expert opinion, 2015) [5], and the 2026 Italian consensus counts transaminases and GGT among the tests to do in primary care for any short stature [4]. The French paediatricians' baseline tests do not include them [2]. Liver disease also lowers IGF-1 [6].
- IgA anti-tissue transglutaminase antibodies (tTG-IgA)
- Total IgA measurement
- TSH
- Free T4
- IGF-1
- Blood karyotype (in girls; signed consent form enclosed)if neededIn a girl of short stature, to look for Turner syndrome [7]; routine in girls of short stature for French paediatricians [2]; the Dutch group reserves it for girls whose height is < -2 SD or more than 1.6 SD below target height [1].
- Urine dipstick (if kidney disease suspected)if needednon-French guidelineLooking for kidney disease (proteinuria, haematuria, glycosuria): the American Family Physician review cites urinalysis among the tests to request when the clinical picture points to kidney disease (expert opinion, 2015) [5], and the 2026 Italian consensus counts it among the tests to do in primary care for any short stature [4]. The French paediatricians' baseline tests look for renal failure and tubulopathy with serum creatinine, electrolytes and bicarbonate, without urinalysis [2].
Imaging
- PA X-ray of the hand and wrist (bone age)
Faltering weight (drop across weight centiles)
Urine tests
- Urine microscopy and culture (looking for urinary tract infection)
Laboratory tests (if the child eats gluten)
- IgA anti-tissue transglutaminase antibodies (tTG-IgA)
- Total IgA measurement
Sources (12)
- Wit JM, Kamp GA, Oostdijk W; Dutch Working Group on Triage and Diagnosis of Growth Disorders in Children. Towards a Rational and Efficient Diagnostic Approach in Children Referred for Growth Failure to the General Paediatrician. Horm Res Paediatr 2019;91(4):223-40.
- Castets S, Reynaud R. Enfant trop petit. Pas à Pas en pédiatrie, Société française de pédiatrie, 2019 (arbre validé par la Société française de pédiatrie et la Société française d'endocrinologie et diabétologie pédiatrique).
- Caisse nationale de l’assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : chapitre 2 (cytogénétique, acte 0901) ; absence d’acte actif de vitesse de sédimentation.
- Mameli C, Cianfarani S, De Sanctis L, et al. Towards a shared diagnostic approach for pediatric short stature: a Delphi consensus of the Italian Society of Pediatrics and the Italian Society for Pediatric Endocrinology and Diabetology. Ital J Pediatr 2026;52:26.
- Barstow C, Rerucha C. Evaluation of Short and Tall Stature in Children. Am Fam Physician. 2015;92(1):43-50.
- Collett-Solberg PF, Ambler G, Backeljauw PF, et al. Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective. Horm Res Paediatr 2019;92(1):1-14.
- Centre de référence des maladies endocriniennes rares de la croissance et du développement. Syndrome de Turner. Protocole national de diagnostic et de soins (PNDS), Haute Autorité de santé, octobre 2021.
- Cohen P, Rogol AD, Deal CL, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 2008;93(11):4210-7.
- National Institute for Health and Care Excellence. Coeliac disease: recognition, assessment and management. NICE guideline NG20, 2 September 2015.
- Husby S, Koletzko S, Korponay-Szabó I, et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr 2020;70(1):141-56.
- National Institute for Health and Care Excellence. Faltering growth: recognition and management of faltering growth in children. NICE guideline NG75, 27 September 2017.
- Homan GJ. Failure to Thrive: A Practical Guide. Am Fam Physician. 2016;94(4):295-299.